Macrogenics Inc (MGNX): Shareholders' Equity
$55.59M
As of 2025-12-31
$42.87M
As of 2026-06-30
-26.8%
3-year compound annual growth
-28.4%
5-year compound annual growth
-15.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $55.59M | -52.1% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $116.06M | -24.0% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $152.61M | +7.5% | 2026-03-09, Balance as of period end |
| 2022-12-31 | $142.01M | -40.7% | 2025-03-20, Balance as of period end |
| 2021-12-31 | $239.62M | -19.0% | 2024-03-07, Balance as of period end |
| 2020-12-31 | $295.88M | +28.3% | 2023-03-15, Balance as of period end |
| 2019-12-31 | $230.63M | -5.0% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $242.88M | -18.8% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $299.24M | +11.3% | 2020-02-25, Balance as of period end |
| 2016-12-31 | $268.75M | -14.2% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $313.34M | +158.3% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $121.29M | +53.7% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $78.91M | n/m | 2016-02-29, Balance as of period end |
| 2012-12-31 | -$8.24M | n/m | 2015-03-03, Balance as of period end |
| 2011-12-31 | -$17.48M | n/a | 2014-03-20, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Macrogenics Inc (MGNX) | 2025-12-31 | $55.59M | -52.1% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $98.88M | +84.8% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$292.93M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $14.33M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | $44.75M | -43.6% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $64.63M | -77.6% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $1.34M | -88.2% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$438.17M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $502.64M | +25.1% |
Compare MGNX, ELTP, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗